CLINICAL TRIAL
COMPARATIVE STUDY
JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Clinical characteristics and long-term follow-up of ketosis-prone diabetes in Thai patients.

INTRODUCTION: Diabetes presenting with ketoacidosis is a heterogeneous disorder. The purpose of this study was to determine whether ketosis-prone diabetes (KPDM) in Thai patients were different from type1 diabetes by assessment of the beta-cell response to a standardized mixed meal and pancreatic autoantibodies.

MATERIAL AND METHODS: 20 patients who were categorized as ketosis-prone diabetes based on the occurrence of unprovoked DKA after the age of 30 years were compared with 12 type1 diabetic patients. The beta-cell function and pancreatic autoantibodies were followed after resolution of DKA every 6 months for 2 years.

RESULTS: Mean (±SD) age at presentation was 38.8±11.5 and 26.7+10.3 years in KPDM and type1 DM, respectively (p<0.05). Median (IQR) fasting plasma C-peptide obtained after resolution of DKA within 2 weeks was 0.90 ng/dl -(0.20-1.30) in KPDM compared with 0.10 ng/dl (0.10-0.45) in type1 diabetes and median peak stimulated plasma C-peptide was 6.80 ng/dl (0.90-9.80) compared with 0.10 ng/dl (0.10-0.75). Based on Aβ classification, 4 patients were classified as A+β-, 12 patients were classified as A-β+, and 4 patients were classified as A-β-. No patient was classified as A+β+ in this study. At the median time of 31 months follow-up (range from 8-44 months), 11 patients from 12 A-β+ KPDM (92%) could be withdrawn from insulin treatment successfully at median time of 5 months after admission.

CONCLUSIONS: Thai KPDM patients had variable clinical course which were different from typical type1 DM. The Aβ classification was proven to be useful predictors for consideration of insulin withdrawal after resolution of DKA.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app